Home
/
Iterum Therapeutics plc
/
Financials
/
Quarterly
Iterum Therapeutics plc — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Iterum Therapeutics plc filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$390.0K
Nov 14, 2025
Q3
2020
Sep 30, 2019
$37.0K
Nov 16, 2020
Q2
2020
Jun 30, 2019
$37.0K
Aug 6, 2020
Q1
2020
Mar 31, 2019
$37.0K
May 14, 2020
Q3
2019
Sep 30, 2018
$254.0K
Nov 12, 2019
Q2
2019
Jun 30, 2018
$185.0K
Aug 14, 2019
Q1
2019
Mar 31, 2018
$191.0K
May 14, 2019
Q3
2018
Sep 30, 2017
$159.0K
Nov 14, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.98M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($6.51M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($4.89M)
May 13, 2025
Q1
2025
Dec 31, 2024
($24.77M)
May 13, 2025
Q3
2025
Dec 31, 2024
($24.77M)
Nov 14, 2025
Q2
2025
Dec 31, 2024
($24.77M)
Aug 5, 2025
Q3
2025
Sep 30, 2024
($6.09M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($5.00M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($7.10M)
May 13, 2025
Q2
2024
Dec 31, 2023
($38.37M)
Aug 14, 2024
Q1
2024
Dec 31, 2023
($38.37M)
May 13, 2024
Q3
2024
Dec 31, 2023
($38.37M)
Nov 14, 2024
Q3
2024
Sep 30, 2023
($3.88M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($12.24M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($9.89M)
May 13, 2024
Q3
2023
Dec 31, 2022
($44.43M)
Nov 14, 2023
Q2
2023
Dec 31, 2022
($44.43M)
Aug 11, 2023
Q1
2023
Dec 31, 2022
$44.43M
May 12, 2023
Q3
2023
Sep 30, 2022
($29.11M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($6.74M)
Aug 11, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.73M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($5.53M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($3.71M)
May 13, 2025
Q3
2025
Sep 30, 2024
($4.89M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($3.98M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($6.16M)
May 13, 2025
Q3
2024
Sep 30, 2023
($16.69M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($10.82M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($8.53M)
May 13, 2024
Q3
2023
Sep 30, 2022
($7.03M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($8.05M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($7.37M)
May 12, 2023
Q3
2022
Sep 30, 2021
($4.87M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($6.99M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($5.85M)
May 13, 2022
Q3
2021
Sep 30, 2020
($6.34M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($8.25M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($12.89M)
May 14, 2021
Q3
2020
Sep 30, 2019
($31.00M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($27.38M)
Aug 6, 2020